New antiviral Covid pill
Oct 06, 2021•29 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Trials stopped early of a new Covid antiviral pill, Molnupiravir, as it may cut numbers of people in hospital by about a half. Claudia Hammond discusses the ethical questions of who should be given it. Plus Unicef report on findings about childhood mental health before and during the pandemic. And a new exhibition on the researchers and trial participants outwitting cancer.
Presenter: Claudia Hammond Producer: Erika Wright
(Photo: An experimental Covid-19 treatment pill called Molnupiravir. Photo credit: Merck/Reuters)
For the best experience, listen in Metacast app for iOS or Android